Record revenue and EBITDA were achieved, driven by strong SaaS and healthcare growth, with a robust pipeline and expanding AI capabilities. Fiscal 2027 guidance calls for continued SaaS and margin expansion, while capital allocation favors share repurchases over M&A.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.